Search This Blog

Wednesday, November 4, 2015

Results of Two Pivotal Baricitinib Trials to be Presented at 2015 American College of Rheumatology Annual Meeting (NYSE:LLY)

Lilly immunology portfolio to be featured in 12 presentations



Results of Two Pivotal Baricitinib Trials to be Presented at 2015 American College of Rheumatology Annual Meeting (NYSE:LLY)

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.